Cinryze Interactions
There are 51 drugs known to interact with Cinryze (C1 esterase inhibitor (human)), along with 1 disease interaction. Of the total drug interactions, 4 are major, 46 are moderate, and 1 is minor.
- View all 51 medications that may interact with Cinryze
- View Cinryze disease interactions (1)
Most frequently checked interactions
View interaction reports for Cinryze (C1 esterase inhibitor (human)) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Afrin (oxymetazoline nasal)
- Aldactone (spironolactone)
- Alecensa (alectinib)
- Allegra (fexofenadine)
- alprazolam
- Ambien (zolpidem)
- amoxicillin / clavulanate
- Ampyra (dalfampridine)
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- Augmentin (amoxicillin / clavulanate)
- clarithromycin
- DHEA (dehydroepiandrosterone)
- doxepin
- esomeprazole
- Firazyr (icatibant)
- icatibant
- Ruconest (conestat alfa)
- Sandostatin (octreotide)
- tacrolimus
- Takhzyro (lanadelumab)
- Triumeq (abacavir / dolutegravir / lamivudine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xolair (omalizumab)
Cinryze disease interactions
There is 1 disease interaction with Cinryze (C1 esterase inhibitor (human)) which include:
Report options
More about Cinryze (C1 esterase inhibitor (human))
- Cinryze consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Firazyr
Firazyr is used to treat acute attacks of hereditary angioedema (HAE) in adults. It can be ...
Ruconest
Ruconest is used to treat angioedema attacks in adult and adolescent patients with Hereditary ...
Orladeyo
Orladeyo (berotralstat) is used to prevent attacks of hereditary angioedema (HAE). Includes ...
Takhzyro
Takhzyro (lanadelumab-flyo) is used to prevent hereditary angioedema (HAE) and reduce symptoms ...
Berinert
Berinert is used to treat acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Icatibant
Icatibant is an injection used to treat acute attacks of hereditary angioedema (HAE) in adults. It ...
Lanadelumab
Lanadelumab injection is a monoclonal antibody used to prevent hereditary angioedema. Includes side ...
Stanozolol
Stanozolol is used in the treatment of hereditary angioedema, which causes episodes of swelling of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
